<DOC>
	<DOCNO>NCT00000995</DOCNO>
	<brief_summary>To evaluate clinical laboratory toxicity ganciclovir ( GCV ) zidovudine ( AZT ) give combination . Because recent information show AZT useful treating AIDS , assume patient AIDS , probably AIDS relate complex ( ARC ) , receive AZT . Because AZT report active cytomegalovirus ( CMV ) , important see useful give GCV along AZT .</brief_summary>
	<brief_title>A Study AZT Plus Ganciclovir Patients With AIDS Cytomegalovirus ( CMV ) Infection</brief_title>
	<detailed_description>Because recent information show AZT useful treating AIDS , assume patient AIDS , probably AIDS relate complex ( ARC ) , receive AZT . Because AZT report active cytomegalovirus ( CMV ) , important see useful give GCV along AZT . Patients place one four group entry study accord previous treatment : I : Prior treatment AZT time develop CMV infection require dose reduction AZT toxicity . II : Prior treatment AZT time develop CMV infection require dose reduction AZT toxicity . III : Prior therapy GCV CMV infection . These patient already maintenance phase , complete minimum 2 week induction therapy . IV : No prior therapy either AZT GCV . Treatment last 24 week consist two treatment plan : A : Patients previously treat GCV start GCV additional 22 week . GCV give 1-hour infusion . All patient start AZT low dose . B : For patient chronic CMV disease receive GCV maintenance , GCV administer 1-hour infusion 5 days/week . AZT add treatment GCV standardize prior begin study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Symptomatic therapy analgesic , antihistamine , antiemetic , antidiarrheal agent , supportive therapy may administer deem necessary responsible investigator . For fever , follow regimen use : If fever 39.0 degree C , antipyretic therapy administer employ aspirin , 650 mg orally every 4 hour x 3 dos , fever fall 39.0 degree C. If fever high 39.0 degree C occur 2 consecutive day , patient may premedicated aspirin . Exclusion Criteria Active alcohol drug abuse . Coexisting Condition : Excluded : Patients lifethreatening uncontrolled opportunistic infection enrollment . Patients follow prior condition exclude : Have lifethreatening uncontrolled opportunistic infection enrollment . Prior Medication : Excluded within 1 week study entry : Systemic therapy antimetabolite . Cytotoxic drug . Interferon . Immunologic modulators . Corticosteroids . Nucleoside analogs zidovudine ( AZT ) . Excluded within 2 week study entry : Therapy opportunistic infection . Excluded within 2 month study entry : Ribavirin . Prior Treatment : Excluded within 2 week study entry ( treatment group I ) : Blood transfusion . Excluded within 1 month study entry ( treatment group II III ) : Blood transfusion . All patient must : Able provide inform consent . Likely available followup least 4 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Ganciclovir</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Cytomegalovirus Infections</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Zidovudine</keyword>
</DOC>